Some of our favourite coverage from Q1 2022
Kazia Therapeutics advances human trials for lead cancer drugs during December quarter.
CSO Dr Daniel Tillett Talks To Proactive About Recent Kidney Cancer Results.
A good night's sleep may be down to bacteria. A Queensland company is pursuing the idea that what’s in your stomach may be causing insomnia.
John Kelly spoke with Jack Crnjanin on Joy 94.9 Radio’s Well Well Well podcast about the Atomo HIV self-test and the health and awareness benefits to come from the TGA’s recent amendments to rules.
Click here to listen to the podcast.
Martin Filz recently spoke with Proactive Investor’s Andrew Scott about Pureprofile and its recent half yearly earnings performance.
Click here to watch
Oventus Medical, incoming CEO, John Cox, speaks with Andrew Scott from Proactive Investors about the innovations and competitive advantage of Oventus’ sleep apnea therapeutic oral device.
Click here to watch
